๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
406 medicines starting with โ€œOโ€
MedicineActive substanceLicence holderStatus
Olanzapine 5mg Film-coated Tablets
PA0126/210/002
Olanzapine Clonmel Healthcare Ltd Marketed
Olanzapine 7.5mg Film-coated Tablets
PA0126/210/003
Olanzapine Clonmel Healthcare Ltd Marketed
Olanzapine Accord 10 mg film-coated tablets
PA2315/112/004
Olanzapine Accord Healthcare Ireland Ltd. Marketed
Olanzapine Accord 15 mg film-coated tablets
PA2315/112/005
Olanzapine Accord Healthcare Ireland Ltd. Marketed
Olanzapine Accord 2.5 mg film-coated tablets
PA2315/112/001
Olanzapine Accord Healthcare Ireland Ltd. Marketed
Olanzapine Accord 5 mg film-coated tablets
PA2315/112/002
Olanzapine Accord Healthcare Ireland Ltd. Marketed
Olanzapine Accord 7.5 mg film-coated tablets
PA2315/112/003
Olanzapine form 1 Accord Healthcare Ireland Ltd. Marketed
Olanzapine Apotex 10 mg film-coated tablets
EU/1/10/635/006-7
Olanzapine Apotex Europe B.V. โ€”
Olanzapine Apotex 10 mg orodispersible tablets
EU/1/10/635/010-11
Olanzapine Apotex Europe B.V. โ€”
Olanzapine Apotex 15 mg orodispersible tablets
EU/1/10/635/012
Olanzapine Apotex Europe B.V. โ€”
Olanzapine Apotex 2.5 mg film-coated tablets
EU/1/10/635/001
Olanzapine Apotex Europe B.V. โ€”
Olanzapine Apotex 20 mg orodispersible tablets
EU/1/10/635/013-14
Olanzapine Apotex Europe B.V. โ€”
Olanzapine Apotex 5 mg film-coated tablets
EU/1/10/635/002-3
Olanzapine Apotex Europe B.V. โ€”
Olanzapine Apotex 5 mg orodispersible tablets
EU/1/10/635/008-9
Olanzapine Apotex Europe B.V. โ€”
Olanzapine Apotex 7.5 mg film-coated tablets
EU/1/10/635/004-5
Olanzapine Apotex Europe B.V. โ€”
Olanzapine Glenmark 10 mg tablets
EU/1/09/587/10-12
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Glenmark 15 mg tablets
EU/1/09/587/13-15
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Glenmark 2.5 mg tablets
EU/1/09/587/1-3
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Glenmark 20 mg tablets
EU/1/09/587/16-17
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Glenmark 5 mg tablets
EU/1/09/587/4-6
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Glenmark 7.5 mg tablets
EU/1/09/587/7-9
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Glenmark Europe 10 mg orodispersible tablets
EU/1/09/588/4-6
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Glenmark Europe 15 mg orodispersible tablets
EU/1/09/588/7-9
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Glenmark Europe 20 mg orodispersible tablets
EU/1/09/588/10-12
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Glenmark Europe 5 mg orodispersible tablets
EU/1/09/588/1-3
Olanzapine Glenmark Arzneimittel GmbH โ€”
Olanzapine Mylan 2.5 mg film-coated tablets
EU/1/08/475/1-6
Olanzapine Mylan Pharmaceuticals Limited โ€”
Olanzapine Mylan 10 mg film-coated tablets
EU/1/08/475/18-24
Olanzapine Mylan Pharmaceuticals Limited โ€”
Olanzapine Mylan 15 mg film-coated tablets
EU/1/08/475/25-29
Olanzapine Mylan Pharmaceuticals Limited โ€”
Olanzapine Mylan 20 mg film-coated tablets
EU/1/08/475/30-34
Olanzapine Mylan Pharmaceuticals Limited โ€”
Olanzapine Mylan 5 mg film-coated tablets
EU/1/08/475/7-12
Olanzapine Mylan Pharmaceuticals Limited โ€”
Olanzapine Mylan 7 mg film-coated tablets
EU/1/08/475/13-17
Olanzapine Mylan Pharmaceuticals Limited โ€”
Olanzapine Teva 10 mg film-coated tablets
EU/1/07/427/11-14
Olanzapine Teva Pharma B.V. โ€”
Olanzapine Teva 15 mg film-coated tablets
EU/1/07/427/16-19
Olanzapine Teva Pharma B.V. โ€”
Olanzapine Teva 2.5 mg film-coated tablets
EU/1/07/427/1-3
Olanzapine Teva Pharma B.V. โ€”
Olanzapine Teva 20 mg film-coated tablets
EU/1/07/427/20-22
Olanzapine Teva Pharma B.V. โ€”
Olanzapine Teva 5 mg film-coated tablets
EU/1/07/427/004-007
Olanzapine Teva Pharma B.V. โ€”
Olanzapine Teva 10 mg Orodispersible tablet
EU/1/07/427/27-30
Olanzapine Teva Pharma B.V. โ€”
Olanzapine Teva 15 mg Orodispersible tablet
EU/1/07/427/31-34
Olanzapine Teva Pharma B.V. โ€”
Olanzapine Teva 20 mg Orodispersible tablet
EU/1/07/427/35-37
Olanzapine Teva Pharma B.V. โ€”
Olanzapine Teva 5 mg Orodispersible tablet
EU/1/07/427/23-26
Olanzapine Teva Pharma B.V. โ€”
Olanzapine Teva 7.5 mg film-coated tablets
EU/1/07/427/008-010
Olanzapine Teva Pharma B.V. โ€”
Olatuton 10 mg powder and solvent for prolonged-release suspension for injection
PA1986/076/001
Octreotide Teva B.V. Not marketed
Olatuton 20 mg powder and solvent for prolonged-release suspension for injection
PA1986/076/002
Octreotide Teva B.V. Not marketed
Olatuton 30 mg powder and solvent for prolonged-release suspension for injection
PA1986/076/003
Octreotide Teva B.V. Not marketed
Olazax 10 mg tablets
EU/1/09/597/003
Olanzapine Glenmark Pharmaceuticals s.r.o. โ€”
Olazax 15 mg tablets
EU/1/09/597/004
Olanzapine Glenmark Pharmaceuticals s.r.o. โ€”
Olazax 20 mg tablets
EU/1/09/597/005
Olanzapine Glenmark Pharmaceuticals s.r.o. โ€”
Olazax 5 mg tablets
EU/1/09/597/001
Olanzapine Glenmark Pharmaceuticals s.r.o. โ€”
Olazax 7.5 mg tablets
EU/1/09/597/002
Olanzapine Glenmark Pharmaceuticals s.r.o. โ€”
Olazax Disperzi
EU/1/09/592/002
Olanzapine Glenmark Pharmaceuticals s.r.o. โ€”
โ† 1 2 3 4 5 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.